Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Combination treatment in Chlamydia-triggered reactive arthritis: comment on the article by Carter et al.

Lauhio A, Saikku P, Salo T, Tschesche H, Lähdevirta J, Sorsa T.

Arthritis Rheum. 2011 Jan;63(1):305-7; author reply 307-8. doi: 10.1002/art.30075. No abstract available.

2.

Characterisation of a novel matrix metalloproteinase inhibitor on pancreatic adenocarcinoma cells in vitro and in an orthotopic pancreatic cancer model in vivo.

Kapischke M, Fischer T, Tiessen K, Tschesche H, Bruch HP, Kalthoff H, Kruse ML.

Int J Oncol. 2008 Jan;32(1):273-82.

PMID:
18097568
3.

Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.

Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, Zuidwijk K, van der Reijden JJ, Hanemaaijer R, Griffioen G, Lamers CB, Verspaget HW.

Eur J Cancer. 2007 Aug;43(12):1869-76. Epub 2007 Jul 2.

PMID:
17604154
4.

Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.

Maskos K, Lang R, Tschesche H, Bode W.

J Mol Biol. 2007 Mar 2;366(4):1222-31. Epub 2006 Dec 1.

PMID:
17196980
5.

Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.

Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F.

J Med Chem. 2006 Feb 9;49(3):923-31.

PMID:
16451058
6.

N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.

Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C.

Bioorg Med Chem Lett. 2006 Jan 1;16(1):20-4. Epub 2005 Oct 18.

PMID:
16242329
7.

ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion.

Beck V, Herold H, Benge A, Luber B, Hutzler P, Tschesche H, Kessler H, Schmitt M, Geppert HG, Reuning U.

Int J Biochem Cell Biol. 2005 Mar;37(3):590-603.

PMID:
15618016
8.
9.

Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.

Diehl P, Hantke B, Hennig M, Tschesche H, Mittelmeier W, Schmitt M, Muehlenweg B.

Int J Mol Med. 2004 May;13(5):711-5.

PMID:
15067375
10.

Distribution of extracellular matrix proteins in pterygia: an immunohistochemical study.

Naib-Majani W, Eltohami I, Wernert N, Watts W, Tschesche H, Pleyer U, Breipohl W.

Graefes Arch Clin Exp Ophthalmol. 2004 Apr;242(4):332-8. Epub 2004 Jan 29.

PMID:
14749931
12.

Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.

Hurst DR, Schwartz MA, Ghaffari MA, Jin Y, Tschesche H, Fields GB, Sang QX.

Biochem J. 2004 Feb 1;377(Pt 3):775-9.

13.

Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients.

Hantke B, Harbeck N, Schmalfeldt B, Claes I, Hiller O, Luther MO, Welk A, Kuhn W, Schmitt M, Tschesche H, Muehlenweg B.

Biol Chem. 2003 Aug;384(8):1247-51.

PMID:
12974393
14.

Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.

Schmaldienst S, Oberpichler A, Tschesche H, Hörl WH.

Kidney Blood Press Res. 2003;26(2):107-12.

15.

Influence of flavonoids and vitamins on the MMP- and TIMP-expression of human dermal fibroblasts after UVA irradiation.

Hantke B, Lahmann C, Venzke K, Fischer T, Kocourek A, Windsor LJ, Bergemann J, Stäb F, Tschesche H.

Photochem Photobiol Sci. 2002 Oct;1(10):826-33.

PMID:
12656486
16.

ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts.

Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ.

Biochemistry. 2002 Dec 24;41(51):15394-403.

PMID:
12484779
17.
18.

Computational study of the catalytic domain of human neutrophil collagenase. specific role of the S3 and S'3 subsites in the interaction with a phosphonate inhibitor.

Aschi M, Roccatano D, Di Nola A, Gallina C, Gavuzzo E, Pochetti G, Pieper M, Tschesche H, Mazza F.

J Comput Aided Mol Des. 2002 Mar;16(3):213-25.

PMID:
12363219
19.

Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.

Krumme D, Tschesche H.

Bioorg Med Chem Lett. 2002 Mar 25;12(6):933-6.

PMID:
11958997
20.

Modulation of the catalytic activity of neutrophil collagenase MMP-8 on bovine collagen I. Role of the activation cleavage and of the hemopexin-like domain.

Gioia M, Fasciglione GF, Marini S, D'Alessio S, De Sanctis G, Diekmann O, Pieper M, Politi V, Tschesche H, Coletta M.

J Biol Chem. 2002 Jun 28;277(26):23123-30. Epub 2002 Apr 12.

21.

Identification of the active site of gelatinase B as the structural element sufficient for converting a protein to a metalloprotease.

Kaur K, Zhu K, Whittemore MS, Petersen RL, Lichte A, Tschesche H, Pourmotabbed T.

Biochemistry. 2002 Apr 16;41(15):4789-97.

PMID:
11939773
22.
23.

MMP-TIMP interaction depends on residue 2 in TIMP-4.

Stratmann B, Farr M, Tschesche H.

FEBS Lett. 2001 Nov 2;507(3):285-7.

24.

Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.

Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W, Maskos K.

J Mol Biol. 2001 Sep 28;312(4):731-42.

PMID:
11575928
25.

Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.

Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H.

J Med Chem. 2001 Sep 27;44(20):3231-43.

PMID:
11563922
26.
27.

Novel heterocyclic inhibitors of matrix metalloproteinases: three 6H-1,3,4-thiadiazines.

Schröder J, Wenzel H, Stammler HG, Stammler A, Neumann B, Tschesche H.

Acta Crystallogr C. 2001 May;57(Pt 5):593-6. Epub 2001 May 15.

PMID:
11353263
28.
29.

The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases.

Tschesche H, Zölzer V, Triebel S, Bartsch S.

Eur J Biochem. 2001 Apr;268(7):1918-28.

30.
31.

Pregnancy-associated plasma protein-E (PAPP-E).

Farr M, Strübe J, Geppert HG, Kocourek A, Mahne M, Tschesche H.

Biochim Biophys Acta. 2000 Oct 2;1493(3):356-62.

PMID:
11018262
32.

Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.

Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R.

J Biol Chem. 2000 Dec 29;275(52):41415-23.

33.

Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design.

Gavuzzo E, Pochetti G, Mazza F, Gallina C, Gorini B, D'Alessio S, Pieper M, Tschesche H, Tucker PA.

J Med Chem. 2000 Sep 7;43(18):3377-85.

PMID:
10978185
34.

Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.

Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H, Fink E.

Biol Chem. 2000 May-Jun;381(5-6):509-16.

PMID:
10937883
35.
36.

The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells.

Eberle K, Oberpichler A, Trantakis C, Krupp W, Knüpfer M, Tschesche H, Seifert V.

Anticancer Res. 2000 May-Jun;20(3A):1679-84.

PMID:
10928091
37.

Expression of human membrane type 1 matrix metalloproteinase in Pichia pastoris.

Roderfeld M, Büttner FH, Bartnik E, Tschesche H.

Protein Expr Purif. 2000 Aug;19(3):369-74.

PMID:
10910727
38.

Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome.

Price B, Dennison C, Tschesche H, Elliott E.

J Biol Chem. 2000 Sep 8;275(36):28308-15.

39.

Matrix metalloproteinases (MMP-8, -13, and -14) interact with the clotting system and degrade fibrinogen and factor XII (Hagemann factor).

Tschesche H, Lichte A, Hiller O, Oberpichler A, Büttner FH, Bartnik E.

Adv Exp Med Biol. 2000;477:217-28. No abstract available.

PMID:
10849749
40.

Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.

Ottl J, Gabriel D, Murphy G, Knäuper V, Tominaga Y, Nagase H, Kröger M, Tschesche H, Bode W, Moroder L.

Chem Biol. 2000 Feb;7(2):119-32.

41.

Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma.

Wilharm E, Parry MA, Friebel R, Tschesche H, Matschiner G, Sommerhoff CP, Jenne DE.

J Biol Chem. 1999 Sep 17;274(38):27331-7.

42.
43.

Insights into MMP-TIMP interactions.

Bode W, Fernandez-Catalan C, Grams F, Gomis-Rüth FX, Nagase H, Tschesche H, Maskos K.

Ann N Y Acad Sci. 1999 Jun 30;878:73-91. Review.

PMID:
10415721
44.

Collagenolysis in the lower uterine segment during parturition at term: correlations with stage of cervical dilatation and duration of labor.

Winkler M, Oberpichler A, Tschesche H, Ruck P, Fischer DC, Rath W.

Am J Obstet Gynecol. 1999 Jul;181(1):153-8.

PMID:
10411812
45.

Structural properties of matrix metalloproteinases.

Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H, Maskos K.

Cell Mol Life Sci. 1999 Apr;55(4):639-52. Review.

PMID:
10357232
46.
47.

The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin.

Coles M, Diercks T, Muehlenweg B, Bartsch S, Zölzer V, Tschesche H, Kessler H.

J Mol Biol. 1999 May 28;289(1):139-57.

PMID:
10339412
48.

Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment.

Winkler M, Fischer DC, Ruck P, Marx T, Kaiserling E, Oberpichler A, Tschesche H, Rath W.

Hum Reprod. 1999 Apr;14(4):1096-100.

PMID:
10221247
50.

Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.

EMBO J. 1998 Sep 1;17(17):5238-48.

Supplemental Content

Loading ...
Support Center